14 results
SC TO-T/A
EX-99
PNT
POINT Biopharma Global Inc.
18 Dec 23
Third party tender offer statement (amended)
6:59am
, transaction costs, risks that the proposed acquisition disrupts current plans and operations or adversely affects employee retention, potentially diverting
SC TO-T/A
EX-99
PNT
POINT Biopharma Global Inc.
4 Dec 23
Third party tender offer statement (amended)
7:04am
costs, risks that the proposed acquisition disrupts current plans and operations or adversely affects employee retention, potentially diverting
SC TO-T/A
EX-99
PNT
POINT Biopharma Global Inc.
17 Nov 23
Third party tender offer statement (amended)
6:53am
costs, risks that the proposed acquisition disrupts current plans and operations or adversely affects employee retention, potentially diverting
SC TO-T/A
EX-99
PNT
POINT Biopharma Global Inc.
15 Nov 23
Third party tender offer statement (amended)
6:51am
, transaction costs, risks that the proposed acquisition disrupts current plans and operations or adversely affects employee retention, potentially
SC TO-T/A
EX-99
2nccurfcr
8 Nov 23
Third party tender offer statement (amended)
5:06pm
SC TO-C
9c6 207q5q6pbu
3 Oct 23
Information about tender offer
4:30pm
SC TO-C
EX-99.1
d7x9ji bo
3 Oct 23
Information about tender offer
4:30pm
SC14D9C
EX-2.1
bqcd9k o69qz
3 Oct 23
Written communication relating to third party tender offer
7:37am
SC14D9C
EX-99.4
3dzq f0lr7
3 Oct 23
Written communication relating to third party tender offer
7:37am
8-K
EX-99.4
kd9kx2 zo
3 Oct 23
Tender and Support Agreement
7:35am
8-K
EX-2.1
e13hq2 8a987b4
3 Oct 23
Tender and Support Agreement
7:35am
DEF 14A
b9fja
28 Apr 22
Definitive proxy
8:36am
- Prev
- 1
- Next